| Literature DB >> 35693463 |
Daria Luschkova1,2, Claudia Traidl-Hoffmann1,2,3,4, Alika Ludwig1,2.
Abstract
The climate crisis poses a major challenge to human health as well as the healthcare system and threatens to jeopardize the medical progress made in recent decades. However, addressing climate change may also be the greatest opportunity for global health in the 21st century. The climate crisis and its consequences, such as rising temperatures, forest fires, floods, droughts, and changes in the quality and quantity of food and water, directly and indirectly affect human physical and mental health. More intense and frequent heat waves and declining air quality have been shown to increase all-cause mortality, especially among the most vulnerable. Climate warming alters existing ecosystems and favors biological invasions by species that better tolerate heat and drought. Pathogen profiles are changing, and the transmission and spread of vector-borne diseases are increasing. The spread of neophytes in Europe, such as ragweed, is creating new pollen sources that increase allergen exposure for allergy sufferers. In addition, the overall milder weather, especially in combination with air pollution and increased CO2 levels, is changing the production and allergenicity of pollen. The phenomenon of thunderstorm asthma is also occurring more frequently. In view of the increasing prevalence of allergic diseases due to climate change, early causal immunomodulatory therapy is therefore all the more important. During a climate consultation, patients can receive individual advice on climate adaptation and resilience and the benefits of CO2 reduction-for their own and the planet's health. Almost 5% of all greenhouse gas emissions in Europe come from the healthcare sector. It thus has a central responsibility for a climate-neutral and sustainable transformation.Entities:
Keywords: Air pollution; COVID-19; Heat wave; Pollen allergenicity; Ragweed; Thunderstorm asthma
Year: 2022 PMID: 35693463 PMCID: PMC9174914 DOI: 10.1007/s40629-022-00212-x
Source DB: PubMed Journal: Allergo J Int ISSN: 2197-0378
Summary of climate change impacts on pollen
| Shift of vegetation zones |
| Changes in onset and duration of the pollen season |
| Increase of airborne pollen concentration |
| Immigration and spread of neophytes (e.g., |
| Increase of pollen allergenicity: changes in allergenic proteins and adjuvant substances in pollen (e.g. pollen-associated lipid mediators (PALMs), lipopolysaccharide (LPS)) |
| Thunderstorm asthma: increased exposure to small allergen fragments during thunderstorms |
→ Effect on time span and severity of symptoms in patients with allergies
Fig. 1Habitat suitability in Europe for Ambrosia artemisiifolia under current climate conditions and the future IPCC climate scenarios RCP 6.0 and RCP 8.5 for the years 2070–2099. Translation figure legend: Derzeitiges Klima current climate. (Modified from Rasmussen et al. [17], Creative Commons CC-BY 4.0)
Fig. 2In “thunderstorm asthma,” aeroallergens are swept into the cloud systems, ruptured through osmotic shock and lightning activity, releasing a variety of respirable allergenic particles. Strong winds can transport these particles over long distances. Downdrafts can concentrate the particles near the ground, leading to a large increase in allergen content in the ambient air. (Modified from Chatelier et al. [23], Creative Commons CC-BY 4.0)
Demands on goverment agencies with regard to allergies
| National Allergy Action Plan |
| Promotion of research in the field of allergology |
| Allergology as mandatory content in education and training of all health professions and for educating and teaching staff |
| Creation of separate and independent full professorships for allergology and for environmental medicine |
| Financial support for information campaigns for the population, e.g., on specific immunotherapy (SIT) |
| Reimbursement of pharmacotherapy of allergic rhinitis by the German statutory health insurance (SHI) |
| Preservation of the prescribing and reimbursement eligibility also of rare allergens for SIT |
| Financial support for the standardization of preparations for SIT and skin testing |
| Securing funding for development, clinical testing and manufacturing of allergy diagnostics |
| Reimbursement of patient training courses for neurodermatitis, anaphylaxis and asthma by the SHI system |
Prescribing preventive medical examinations or occupational entry counseling for occupations with special hazards [31, 37]
Research needs for adaptation to climate change
| Primary prevention | Funding of basic, applied or clinical research in the field of immunology and allergology: allergen research, research into sensitization pathways, development and chronification of allergic diseases |
| Research on protective environmental factors with regard to allergies (biodiversity, traditional lifestyle) | |
| Exploring the barrier function and microbiome of the skin, gut and respiratory tract | |
| Significance of psychosocial factors on development and manifestation of allergic diseases | |
| Changing atmospheric circulation patterns: impact on pollen concentration quantification | |
| Long-term trends in ragweed allergy in Germany | |
| Secondary prevention | Promote studies on interaction between exposome, environmental risks and allergic diseases; better disseminate their results |
| Improvement of molecular diagnostics, development of new allergen therapeutics | |
| Biomarkers for selection of appropriate patients and prognosis determination for specific immunotherapy (SIT) | |
| Response to systemic therapies under different environmental factors such as heat, UV radiation, pollen exposure | |
| Effects of the microbiome on allergic diseases | |
| Individual pollen monitoring | |
| Personalized early warning systems (e.g., thunderstorms for pollen allergy sufferers) |